On January 7th, Labquality and Artimed, Clinical Consulting, Kasve and Prisma CRO merge under the brand of Aurevia, a European company advancing healthcare, pharmaceuticals, and medical technology development. Aurevia is supported by Mérieux Equity Partners.
Under Aurevia, external quality assessments (EQAS), regulatory affairs and quality assurance, clinical research and auditing form a new powerhouse—not only a full-service contract research organization experienced in pharmaceuticals, Medical Devices, in vitro diagnostic devices, but also a trusted EQA partner ensuring that clinical laboratory quality standards are met. Aurevia has offices in Finland, Germany, Poland and Sweden and wide networks of industry partners and customers in Europe and across the globe.
This merger allows us to combine our expertise, innovation, and capabilities to deliver a fuller offering of services more efficiently, while keeping our people focused, flexible and practical approaches.
While our company and brand are evolving, the people you have collaborated with are still there for you. Your existing contacts and projects will continue uninterrupted, now backed by the enhanced resources of our united team. Also our contracts, NDAs and bank accounts will remain the same. Our email addresses follow the format firstname.lastname@aurevia.com.
Also Scandinavian CRO and QAdvis are part of Aurevia.